Morning Breakouts

Latest California Healthline Stories

In Midst Of Raucous Debate Over 340B Drug Discount Program, Lawmaker Introduces Bill To Address Concerns

The measure from Rep. Doris Matsui (D-Calif.) could clarify the intent of the program and define which patients are eligible — two bones of contention over the program, which requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients.

As Insurance Coverage Expands Under Health Law, These Hospitals Adapt To Increase In Demand

“When you have new insurance and you can’t get to a physician and you can’t get to primary care, you’re going to go the emergency departments,” said Dr. Alp Arkun, of Kaiser Fontana and Ontario, one of the hospitals. “It’s a lot of what we were seeing before. Patients are seeking care more, fortunately and more easily with the ACA.”

University Of California Nabs Two Patents In Epic Battle Over CRISPR Technology

But the claims in the patent issued “are extremely narrow and would have little or no effect on the CRISPR field,” said a spokesman for the Broad Institute of MIT and Harvard, which hold the foundational CRISPR patents.

‘This Is Like Some Kind Of Sick Joke’: Senators Get Fired Up Over Pre-Existing Conditions Provision At Azar Hearing

Democratic lawmakers questioned HHS Secretary Alex Azar about why the Trump administration backed away from defending the health law’s provision that protects people with pre-existing conditions. Azar said the decision was driven by constitutional considerations not policy ones. Meanwhile, Senate Majority Leader Mitch McConnell (R-Ky.) says that “everybody” he knows in the Senate wants to keep pre-existing conditions protections in place.

Congress Is About To Consider 57 Bills On Opioid Crisis. But Will The Measures Do Anything To Curb The Epidemic?

Even as lawmakers gear up to consider a sweeping package of opioid bills, some experts are doubtful the legislation will do enough to address the crisis. However, the bipartisan support for the measures speaks to the fact that lawmakers know it’s a winning topic for the upcoming midterms. Meanwhile, NIH has laid out its $500 million plan to combat the epidemic.

More Than One-Third Of Americans Take A Medication That Has Depression As Potential Side Effect

The side effect was well known in some of the drugs, but to see it listed on others was a surprise, the study’s authors say. The topic of suicide and depression has been thrust into the spotlight following two celebrity deaths and a startling CDC report last week.

Data Breach That Exposed Dignity Health Patients’ Information Draws Federal Scrutiny

In April, Dignity inadvertently sent misaddressed emails to patients that contained the wrong person’s name and, in some cases, the patient’s doctor’s name. Dignity said the problem originated from an email list formatted by one of its vendors.